Cardinal Health’s stock price has been highly volatile over the past year, fluctuating between $96.05 and $168.44, with analysts closely monitoring the company’s performance and quarterly earnings reports.
Cardinal Health Inc has experienced significant growth, with its stock price increasing by over 216% in the past five years, driven by its commitment to delivering high-quality healthcare solutions and adapting to the evolving healthcare landscape.
Cardinal Health has launched the One Voice Initiative, a program to amplify the voice of independent pharmacists in policy-making through financial support and industry partnerships.
Cardinal Health Inc. has raised its FY25 earnings guidance and set a long-term growth target, signaling a commitment to sustained growth and value creation.
Cardinal Health has launched a groundbreaking medical device, the Kendall DL Multi System, which enables continuous monitoring of three vital signs in a single platform, revolutionizing patient care and driving efficiencies in hospitals.